Cat. No. | Product name | CAS No. |
DC9450 |
(R)-Baclofen
(R)-Baclofen(STX209) is a selective GABAB receptor agonist. |
69308-37-8 |
DCE-016 |
Chenodeoxycholic acid
>98%,Standard References |
474-25-9 |
DC11919 |
Arimoclomol
Featured
A nontoxic heat shock protein (HSP) coinducer and potentiator of the heat shock response. |
289893-25-0 |
DC11920 |
Arimoclomol maleate
Featured
A nontoxic, orally active heat shock protein (HSP) coinducer and potentiator of the heat shock response. |
289893-26-1 |
DC11515 |
Azeloprazole
A novel potent proton pump inhibitor that irreversibly inhibits H+,K+-ATPase activity with IC50 of 0.28 uM. |
955095-45-1 |
DC11607 |
JTZ-951(Enarodustat)
Featured
A novel potent, orally active HIF prolyl hydroxylase (PHD) inhibitor with IC50 of 0.22 uM for PHD2. |
1262132-81-9 |
DC11608 |
JTZ-951 hydrochloride
A novel potent, orally active HIF prolyl hydroxylase (PHD) inhibitor with IC50 of 0.22 uM for PHD2. |
1262131-60-1 |
DC11546 |
Azeloprazole sodium
A novel potent, orally active proton pump inhibitor that irreversibly inhibits H+,K+-ATPase activity with IC50 of 0.28 uM. |
955095-47-3 |
DC11533 |
PH-46A N-Methyl-D-Glucamine salt
A potent, first-in-class, oral small-molecule agent for the treatment of inflammatory bowel diseases.. |
1380445-04-4 |
DC11532 |
PH-46A
A potent, first-in-class, oral small-molecule agent for the treatment of inflammatory bowel diseases.. |
1421332-97-9 |
DC11518 |
Cavosonstat
Featured
Cavosonstat is a potent, orally bioavailable inhibitor of S-nitrosoglutathione reductase (GSNOR) and CFTR modulator. |
1371587-51-7 |
DC11519 |
Ceclazepide
A potent, selective cholecystokinin receptor CCK2 antagonist for treatment of gastroesophageal reflux disease (GERD).. |
1801749-44-9 |
DC11688 |
Avacopan
Featured
Avacopan is a potent, selective, orally availale C5aR (CD88) inhibitor with IC50 of 0.1 nM. |
1346623-17-3 |
DC11525 |
Mocravimod
A synthetic immunosuppressant that functions as a S1P1 receptor agonist. |
509092-16-4 |
DC9986 |
Acebilustat(ZK322)
Featured
Acebilustat(ZK322) is a potent and selective leukotriene A4 hydrolase inhibitor. |
943764-99-6 |
DC11512 |
Acrizanib
Featured
Acrizanib(LHA510) is a potent and selective angiogenesis inhibitor and VEGFR‑2 Inhibitor Specifically Designed for Topical Ocular Delivery, as a Therapy for Neovascular Age-Related Macular Degeneration. |
1229453-99-9 |
DC10234 |
Alosetron Hydrochloride
Alosetron Hydrochloride is the hydrochloride salt form of alosetron, a potent and selective 5-HT3 receptor antagonist. |
122852-69-1 |
DC8606 |
Alvimopan monohydrate
Alvimopan(LY 246736; ADL 8-2698) is a peripherally acting mu-opioid receptor (PAM-OR, IC50= 1.7 nM) antagonist for accelerating gastrointestinal recovery after surgery. |
1383577-62-5 |
DC8605 |
Alvimopan dihydrate
Alvimopan(LY 246736; ADL 8-2698) is a peripherally acting mu-opioid receptor (PAM-OR, IC50= 1.7 nM) antagonist for accelerating gastrointestinal recovery after surgery. |
170098-38-1 |
DC11076 |
Ampreloxetine
Ampreloxetine (TD-9855) is a potent monoamine reuptake inhibitor with pIC50 of 8.0, 8.6 and 6.8 for human NET, SERT, and DAT, respectively. |
1227056-84-9 |
DC9034 |
Atomoxetine HCl
Atomoxetine Hcl(LY 139603; Tomoxetine Hcl) is a potent and selective noradrenalin re-uptake inhibitor (Ki values are 5, 77 and 1451 nM for inhibition of radioligand binding to human NET, SERT and DAT respectively). |
82248-59-7 |
DC8971 |
Baclofen
Baclofen is a gamma-amino-butyric acid (GABA) derivative used as a skeletal muscle relaxant. |
1134-47-0 |
DC8895 |
benzbromaron
Featured
Benzbromarone is a highly effective and well tolerated non-competitive inhibitor of xanthine oxidase, used as an uricosuric agent, used in the treatment of gout. |
3562-84-3 |
DC10459 |
BMS-986020
Featured
BMS-986020 is an LPA1 antagonist. |
1257213-50-5 |
DC11354 |
Carteolol (hydrochloride)
Carteolol is an antagonist of β-adrenergic receptors (Kd = 13 nM). |
51781-21-6 |
DC4160 |
CB-03-01
Featured
CB-03-01 is a steroidal ester, androgen antagonist derived from 11-deoxycortisone, which tightly mimics the profile of an ideal anti-androgen for topical use. |
19608-29-8 |
DC10868 |
Cilofexor
Featured
Cilofexor (GS-9674, GS9674) is novel specific, non-steroidal farnesoid X receptor (FXR) agonist that reduces liver fibrosis and ameliorates portal hypertension in rat NASH models. |
1418274-28-8 |
DC9183 |
Clomiphene citrate
Clomifene Citrate is a selective estrogen receptor modulator. |
50-41-9 |
DCAPI1091 |
Conivaptan hydrochloride
Featured
Conivaptan(YM 087) is a non-peptide inhibitor of antidiuretic hormone (vasopressin receptor antagonist) with Ki values of 0.48 and 3.04 nM for rat liver V1A receptor and rat kidney V2 receptor respectively. |
168626-94-6 |
DC4132 |
CP-547632
Featured
CP-547632 is as a potent inhibitor of the VEGFR-2 and basic fibroblast growth factor (FGF) kinases (IC50 11 and 9 nM, respectively). |
252003-65-9 |
DC9278 |
CWHM-12
Featured
CWHM-12 a novel small molecule inhibitor of αV integrins with IC50s of 1.8/0.8/1.5/0.2 nM for αvβ1/αvβ3/αvβ8; less potency on αvβ5(IC50=61 nM) and on inhibition on αIIbβ3/α2β1/α10β1. |
1564286-55-0 |
DC11082 |
Danicopan (ACH-4471)
Featured
Danicopan (ACH-4471, ACH-0144471) is a highly potent, orally active Factor D inhibitor with Kd of 0.54 nM, inhibits the proteolytic activity of purified Factor D against substrate Factor B in complex with C3b, blocking production of Bb fragment IC50 of 15 nM. |
1903768-17-1 |
DC9116 |
Dantrolene sodium
Dantrolene sodium is a inhibitor of calcium channel proteins, inhibiting the release of Ca2+ from the sarcoplasm. Dantrolene sodium is a skeletal muscle relaxant which acts by blocking muscle contraction beyond the neuromuscular junction. |
14663-23-1 |
DC8188 |
Daprodustat
Featured
Daprodustat(GSK1278863) isa HIF-prolyl hydroxylase inhibitor. |
960539-70-2 |
DCAPI1107 |
Deferasirox (Exjade)
Featured
Deferasirox (Exjade) |
201530-41-8 |
DC9604 |
Desogestrel
Featured
Desogestrel(Org-2969) is a third-generation 19-nortestosterone derivative progestogen; is contained in many oral contraceptive preparations, both combined (COCs) to ethinyl-estradiol (EE) or alone in a progestin-only pill (POP). |
54024-22-5 |
DC9434 |
DMP 777
DMP 777(L-694458) is a potent, selective, and orally active human leukocyte elastase (HLE) inhibitor. |
157341-41-8 |
DC8485 |
E-64d(Aloxistatin)
Featured
E-64D is an inhibitor of cathepsins B and L; also thought to inhibit calpain,showed a potent activity for COVID-19(SARS-COV-2)with EC50: MERS-COV(1.275),SARS-COV(0.760) |
88321-09-9 |
DC10939 |
Edasalonexent
Edasalonexent (CAT-1004) is a bifunctional, orally administered small molecule that covalently links 2 compounds known to inhibit NF‐κB, salicylic acid and docosahexaenoic acid (DHA). |
1204317-86-1 |
DC8626 |
Eluxadoline
Featured
Eluxadoline is an orally active mixed μ opioid receptor (μOR) agonist δ opioid receptor (δOR) antagonist. |
864821-90-9 |
DC9771 |
ACU4429,ACU 4429,ACU-4429
Featured
Emixustat hydrochloride strongly inhibits 11-cis-retinol production with IC50 values of 232 ± 3 nM. |
1141934-97-5 |
DC10314 |
Emixustat
Emixustat, a novel visual cycle modulator, is an inhibitor of the visual cycle isomerase with an IC50 value of 4.4 nM in vitro. |
1141777-14-1 |
DC9762 |
Emricasan
Featured
Emricasan (IDN-6556, PF-03491390) is a potent irreversible pan-caspase inhibitor. |
254750-02-2 |
DC11433 |
Vatiquinone
EPI-743 (Vatiquinone,EPI-589) is an orally bioavailable para-benzoquinone for treatment of inherited mitochondrial diseases, an analogue of the antioxidant ubidecarenone. |
1213269-98-7 |
DC10040 |
Etrasimod(APD334)
Featured
Etrasimod (APD334) is a potent, selective and orally available antagonist of the sphingosine-1-phosphate-1(S1P1) receptor with an IC50 value of 1.88 nM in CHO cells. |
1206123-37-6 |
DC9821 |
Ezutromid
Featured
Ezutromid is a novel Small utrophin's translation modulator with EC50 of 0.4 uM . |
945531-77-1 |
DC8912 |
Fesoterodine fumarate
Featured
Fesoterodine Fumarate is an antimuscarinic agent and is rapidly de-esterified to its active metabolite 5-hydroxymethyl tolterodine that is a muscarinic receptor antagonist. |
286930-03-8 |
DC5193 |
Roxadustat(FG-4592)
Featured
FG-4592 is an HIF αprolyl hydroxylase inhibitor, stabilizes HIF-2 and induces EPO production. |
808118-40-3 |
DC11187 |
Fonadelpar
Fonadelpar (NPS-005,SJP-0035) is a potent, selective peroxisome proliferator activated receptor δ (PPARδ) agonist for the treatment of corneal disorders.. |
515138-06-4 |
DC6917 |
Vonoprazan
Featured
For the detailed information of Vonoprazan, the solubility of Vonoprazan in water, the solubility of Vonoprazan in DMSO, the solubility of Vonoprazan in PBS buffer, the animal experiment (test) of Vonoprazan, the cell expriment (test) of Vonoprazan, the in vivo, in vitro and clinical trial test of Vonoprazan, the EC50, IC50,and affinity,of Vonoprazan, For the detailed information of Vonoprazan, the solubility of Vonoprazan in water, the solubility of Vonoprazan in DMSO, the solubility of Vonoprazan in PBS buffer, the animal experiment (test) of Vonoprazan, the cell expriment (test) of Vonoprazan, the in vivo, in vitro and clinical trial test of Vonoprazan, the EC50, IC50,and affinity,of Vonoprazan, Please contact DC Chemicals.. |
881681-00-1 |
DC11394 |
Fulacimstat(BAY 1142524)
Featured
Fulacimstat(BAY 1142524) is a small molecule chymase inhibitor. |
1488354-15-9 |
DC9859 |
GAL-021
Featured
GAL-021 is a new intravenous BKCa-channel blocker. |
1380341-99-0 |
DC10474 |
GBT-440(Voxelotor)
Featured
GBT-440(Voxelotor) is a novel small molecule hemoglobin modifier which increases hemoglobin oxygen affinity. |
1446321-46-5 |
DC11803 |
GLPG-1690(Ziritaxestat)
Featured
GLPG-1690 is a first-in-class, potent, competitive autotaxin inhibitor with Ki/IC50 of 15 nM/131 nM. |
1628260-79-6 |
DC10753 |
GLPG-1837(ABBV-974)
Featured
GLPG-1837(ABBV-974) is a novel cystic fibrosis transmembrane conductance regulator CFTR potentiator. |
1654725-02-6 |
DC11678 |
GLPG-2222
GLPG-2222 (ABBV-2222, Galicaftor) is a novel potent and efficacious CFTR corrector with EC50 of 5 nM. |
1918143-53-9 |
DC9738 |
GSK2881078
Featured
GSK2881078 (GSK-2881078 ) is a selective androgen receptor modulator (SARM). |
1539314-06-1 |
DC10936 |
GSK3179106
Featured
GSK3179106 (GSK-3179106, GSK 3179106) is a potent, selective, first-in-class and gut-restricted with IC50 of 0.4 and 11 nM in the biochemical assay and cellular assay respectively. |
1627856-64-7 |
DC8166 |
Molidustat(BAY 85-3934)
Featured
Hypoxia-inducible factor prolyl hydroxylase inhibitor |
1154028-82-6 |
DC10007 |
Ibiglustat(Genz-682452)
Featured
Ibiglustat (Genz-682452,SAR402671), is a potent and selective Glucosylceramide synthase inhibitor and ceramide glucosyltransferase inhibitor. |
1401090-53-6 |
DC10205 |
Ilaprazole
Featured
Ilaprazole (IY-81149) is a proton pump inhibitor; inhibits H+/K+-ATPase with an IC50 of 6.0 μM. |
172152-36-2 |
DC7430 |
Obeticholic acid (INT-747)
Featured
INT-747(Obeticholic acid; 6-ECDCA) is a potent and selective FXR agonist(EC50=99 nM) endowed with anticholestatic activity. |
459789-99-2 |
DC7172 |
IOWH-032
iOWH032 is a novel and potent CFTR inhibitor (IC50=1.01 uM) in T84 and CHO-CFTR cell based assays. |
1191252-49-9 |
DC4128 |
Ivacaftor (VX-770)
Featured
Ivacaftor (VX-770, Kalydeco) is a potentiator of CFTR targeting G551D-CFTR and F508del-CFTR with EC50 of 100 nM and 25 nM, respectively. |
873054-44-5 |
DC12374 |
JNJ-10229570
Featured
JNJ-10229570 (JNJ10229570) is a novel potent, selective melanocortin receptor MC1R and MC5R antagonist with binding IC50 of 270 nM and 200 nM, respectively. |
524923-88-4 |
DC10853 |
LAU159
Featured
LAU159 is a novelα6β3γ2 GABAA receptor inhibitor. |
2055050-87-6 |
DC12386 |
Leniolisib (CDZ173)
Featured
Leniolisib (CDZ173) is a potent and selective PI3Kδ inhibitor currently in phase II/III clinical trials for the treatment of immunodeficiency disorders. |
1354690-24-6 |
DC7633 |
Ligandrol (VK5211, LGD-4033)
Featured
LGD-4033 is a novel selective androgen receptor modulator (SARM) |
1165910-22-4 |
DC9938 |
Lusutrombopag(S-888711)
Featured
Lusutrombopag(S-888711) is an orally bioavailable, small molecule thrombopoietin (TPO) receptor agonist being developed by Shionogi for chronic liver disease (CLD) patients with thrombocytopenia prior to elective invasive surgery. |
1110766-97-6 |
DC11524 |
Mavacamten(MYK-461)
Featured
Mavacamten(MYK-461)is a small molecule that reduces contractility by decreasing the ATPase activity of the cardiac myosin heavy chain. |
1642288-47-8 |
DC9527 |
Methylnaltrexone (Bromide)
Featured
Methylnaltrexone Bromide is a pheriphally-acting μ-opioid antagonist that acts on the gastrointestinal tract to decrease opioid-induced constipation. |
73232-52-7 |
DC9995 |
MGL-3196(Resmetirom)
Featured
MGL-3196 is a potent and highly selective thyroid hormone receptor β agonist in clinical trials for the treatment of dyslipidemia. |
920509-32-6 |
DC10326 |
Mozavaptan
Mozavaptan (OPC31260) is a orally effective, nonpeptide vasopressin V2 receptor antagonist with an IC50 of 14 nM. |
137975-06-5 |
DC10173 |
Firsocostat(ND-630,GS-0976)
Featured
ND-630 is an acetyl-CoA carboxylase (ACC) inhibitor; inhibits human ACC1 and ACC2 with IC50 values of 2.1 and 6.1 nM, respectively. |
1434635-54-7 |
DCAPI1342 |
Nepafenac
Nepafenac |
78281-72-8 |
DC9520 |
NKP608
NKP608 is a non-peptidic derivative of 4-aminopiperidine which acts as a selective, specific and potent antagonist at the neurokinin-1 (NK-1) receptor both in vitro(IC50=2.6 nM) and in vivo. |
177707-12-9 |
DC12298 |
Octreotide acetate (SMS 201-995 (acetate))
Featured
Octreotide acetate, a long-acting synthetic analog of native somatostatin, inhibits growth hormone, glucagon, and insulin more potently. |
79517-01-4 |
DC11096 |
Olacaftor
Olacaftor (VX-440, VX440) is a next-generation CFTR corrector, showsthe potential to enhance the amount of CFTR protein at the cell’s surface and for treatment of cystic fibrosis.. |
1897384-89-2 |
DC8390 |
Oltipraz
Featured
Oltipraz is a potent Nrf2 activator and a potent inducer of Phase II detoxification enzymes, most notably glutathione-S-transferase (GST). Phase 3. |
64224-21-1 |
DC10299 |
Olumacostat glasaretil
Olumacostat glasaretil is a small molecule inhibitor of acetyl coenzyme A carboxylase (ACC). |
1261491-89-7 |
DC11044 |
Omidenepag Isopropyl
Featured
Omidenepag Isopropyl (DE-117, OMDI) is the prodrug of Omidenepag, which is a potent, selective agonist human EP2 receptor; demonstrates excellent IOP-lowering activities following ocular administration in ocular normotensive monkeys, Omidenepag Isopropyl (OMDI) is a clinical candidate for the treatment of glaucoma. |
1187451-19-9 |
DC9876 |
Pantoprazole
Pantoprazole is a proton pump inhibitor used for short-term treatment of erosion and ulceration of the esophagus caused by gastroesophageal reflux disease. |
102625-70-7 |
DC9135 |
Pantoprazole Sodium
Pantoprazole sodium salt(SKF96022; Protonix) is a proton pump inhibitor drug used for short-term treatment of erosion and ulceration of the esophagus caused by gastroesophageal reflux disease. |
138786-67-1 |
DC11100 |
PBI-4050 sodium
PBI-4050 (Setogepram, PBI4050) is a synthetic analog of a medium-chain fatty acid that displays agonist and antagonist ligand affinity toward GPR40 and GPR84, respectively. |
1254472-97-3 |
DC11099 |
PBI-4050
PBI-4050 (Setogepram, PBI4050) is a synthetic analog of a medium-chain fatty acid that displays agonist and antagonist ligand affinity toward GPR40 and GPR84, respectively. |
1002101-19-0 |
DC8353 |
PF-04418948
Featured
PF-04418948 is an orally active, potent, and selective EP2 receptor antagonist (IC50 = 16 nM). |
1078166-57-0 |
DCAPI1305 |
Pramiracetam
Pramiracetam |
68497-62-1 |
DC9162 |
Ranolazine HCl
Featured
Ranolazine(RS-43285) is an antianginal agent with antiarrhythmic properties that achieves its effects via a novel mechanism of action (inhibition of the late phase of the inward sodium current), without affecting heart rate or blood pressure (BP). |
95635-56-6 |
DC1048 |
Rapamycin (Sirolimus)
Featured
Rapamycin (Sirolimus, AY-22989, WY-090217) is a specific mTOR inhibitor with IC50 of ~0.1 nM. - |
53123-88-9 |
DC8185 |
Verosudil(AR-12286)
Rho-kinase (ROCK) inhibitor |
1414854-42-4 |
DC10583 |
RO 5028442
Featured
RO5028442 is a highly potent and selective Brain-Penetrant Vasopressin 1a (V1a) receptor antagonist with Kis of 1 nM (hV1a) and 39 nM (mV1a). |
920022-47-5 |
DC8198 |
RTA-408(Omaveloxolone)
Featured
RTA-408 is a synthetic triterpenoid that potently activates the antioxidative transcription factor Nrf2 and inhibits the proinflammatory transcription factor NF-κB. |
1474034-05-3 |
DC8224 |
Lifitegrast(SAR 1118)
Featured
SAR 1118 is a potent tetrahydroisoquinoline (THIQ)-derived LFA-1/ICAM-1 antagonist for treating dry eye. |
1025967-78-5 |
DC10925 |
SAR-100842
Featured
SAR-100842 (SAR100842) is a potent, selective, orally available antagonist of the Lysophosphatidic Acid 1 Receptor (LPA1 receptor) with IC50 of 31 nM in β-arrestin assays. |
1195941-38-8 |
DC9600 |
Senicapoc
Featured
Senicapoc(ICA17043) is a potent and selective Gardos channel blocker; blocked Ca(2+)-induced rubidium flux from human RBCs/ inhibited RBC dehydration with IC50s of 11 nM/30 nM, respectively. IC50 value: 11/30 nM [1] Target: Gardos channel in vitro: I |
289656-45-7 |
DCAPI1485 |
Silodosin
Featured
Silodosin(Rapaflo) is an α1-adrenoceptor antagonist with high uroselectivity. Silodosin causes practically no orthostatic hypotension (in contrast to other α1 blockers). Since Silodosin is a highly selective inhibitor of the α1A adrenergic receptor, it ca |
160970-54-7 |
DC8592 |
Sivelestat (sodium salt hydrate)
Featured
Sivelestat(ONO5046; LY544349; EI546) is a competitive inhibitor of human neutrophil elastase(IC50 = 44 nM; Ki=200 nM); also inhibited leukocyte elastase obtained from rabbit, rat, hamster and mouse. |
201677-61-4 |
DC8500 |
SKQ1(Visomitin)
Featured
SKQ1 prevents amyloid-beta-induced impairment of long-term potentiation in rat hippocampal slices. |
934826-68-3 |
DC9732 |
Sufugolix(TAK-013)
Featured
Sufugolix(TAK-013) is a non-peptide, orally-active, selective antagonist of the gonadotropin-releasing hormone receptor (GnRHR) (IC50 = 0.1 and 0.06 nM for affinity and in vitro inhibition, respectively). |
308831-61-0 |
DC7306 |
TAK-438
Featured
TAK-438 is a novel P-CAB (potassium-competitive acid blocker) that reversibly inhibits H+/K+, ATPase with IC50 of 19 nM (pH 6.5), controls gastric acid secretion. |
1260141-27-2 |
DC10390 |
TD139
Featured
TD139 is a novel high-affinity inhibitor of the galectin-3 carbohydrate binding domain with a Kd of 14 nM. |
1450824-22-2 |
DC11026 |
Tecovirimat
Featured
Tecovirimat (ST-246, Tpoxx) is a potent, orally bioavailable, first-in-class inhibitor of orthopoxvirus egress with EC50 of 0.01-0.6 uM against a panel of Orthopoxviruses; ST-246 is active against multiple orthopoxviruses, including vaccinia, monkeypox, c |
869572-92-9 |
DC9148 |
Tolvaptan
Featured
Tolvaptan is a selective, competitive arginine vasopressin receptor 2 antagonist with an IC50 of 1.28μM for the inhibition of AVP-induced platelet aggregation. |
150683-30-0 |
DC11385 |
Trofinetide(NNZ2566)
Featured
Trofinetide (NNZ-2566) is an analog of a molecule which is derived from IGF-1 and occurs naturally in the brain. IGF-1 is a growth factor stimulated by growth hormone. |
853400-76-7 |
DC10737 |
Tropifexor (LJN452)
Featured
Tropifexor (LJN452) is a highly potent non-bile Acid FXR Agonist for the Treatment of Cholestatic Liver Diseases and Nonalcoholic Steatohepatitis (NASH). |
1383816-29-2 |
DC10083 |
UK-371804
Featured
UK-371804 is a potent and selective uPA inhibitor with excellent enzyme potency (Ki 10 nM) and selectivity profile (4000-fold versus tPA and 2700-fold versus plasmin). |
256477-09-5 |
DC10339 |
Vadadustat
Featured
Vadadustat is a novel, titratable, oral hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor in development for the treatment of anemia. |
1000025-07-9 |
DC9816 |
Valbenazine(NBI-98854)
Featured
Valbenazine(NBI-98854) is a potent and selective VMAT2 inhibitor.. |
1025504-45-3 |
DC1059 |
Lumacaftor(vx-809,vx809)
Featured
VX-809 is a CFTR modulator with EC50 of 0.1 μM. |
936727-05-8 |
DC9187 |
Mosapride Citrate
Mosapride citrate is a gastroprokinetic agent that acts as a selective 5HT4 agonist. |
112885-42-4 |
DC9873 |
Selonsertib(GS-4997)
Featured
Selonsertib(GS-4997)is an orally bioavailable inhibitor of apoptosis signal-regulating kinase 1 (ASK1), with potential anti-inflammatory, antineoplastic and anti-fibrotic activities. |
1448428-04-3 |